Search Parkinson.org

Clinical & Scientific Advisory Board

NPF is moving to a more participatory governance style by creating a new Clinical and Scientific Advisory Board (CSAB) to guide and implement the Centers program. The CSAB will perform peer review accreditation processes, set research agendas, direct clinical research programs, issue request-for-application (RFAs), and form grant review committees. The CSAB will meet formally once a year and will replace both the Scientific Advisory Board and the Centers Review Board.

The current CSAB members, all of whom donate their time and talents without charge, are the following:

Ariel Y. Deutch, Ph.D., Chief Scientific Advisor & Chair
Vanderbilt University Medical Center
Nashville, Tennessee

Michael S. Okun, M.D., National Medical Director
University of Florida
Gainesville, FL

Lisette K. Bunting-Perry, N.R.N.
Philadelphia VAMC
Philadelphia, Pennsylvania

Robert H. Edwards, M.D.
University of California, San Francisco
San Francisco, California

Mark Guttman, M.D., FRCPC
Markham Stouffville Hospital
Markham, Ontario, CANADA

Franz F. Hefti, Ph.D.
Avid Radiopharmaceuticals, Inc.
Philadelphia, Pennsylvania

Joseph Jankovic, M.D.
Baylor College of Medicine
Houston, Texas

Laura Marsh, M.D.
Baylor College of Medicine
Houston, Texas

Ronald F. Pfeiffer, M.D.
University of Tennessee Health Science
Memphis, Tennessee

Ian J. Reynolds, Ph.D.
Merck Research Laboratories
West Point, Pennsylvania

Richard Smeyne, Ph.D.
St. Jude Children's Research Hospital
Memphis, Tennessee

Matthew B. Stern, M.D.
University of Pennsylvania
Philadelphia, Pennsylvania

A. Jon Stoessl, M.D., FRCPC
University of British Columbia
Vancouver, British Columbia, CANADA

Jeffery M. Vance, M.D., Ph.D.
University of Miami - Miller School of Medicine
Miami, Florida

Print